BPA Call FA239625AB007-FA239625FB247
- Not listed
- The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call valued at $58,829.39 to Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and reagents. This firm fixed-price contract, which was not set aside for small businesses, was executed on August 6, 2025, with an ultimate completion date of the same day. The award represents a task order under Werfen's existing BPA vehicle with the Defense Health Agency for the supply of specialized...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency to Werfen USA LLC, a for-profit limited liability company based in Bedford, Massachusetts. The $23,978.70 contract is for the provision of laboratory supplies. The award does not have a small business set-aside designation, indicating Werfen USA LLC competed as a full-sized contractor. The company has several significant Indefinite Delivery/Indefinite Quantity (IDIQ) and BPA contract vehicles...
- The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call to Werfen USA LLC for consumable reagents valued at $14,877.28. This firm fixed-price contract, which was awarded and completed on August 8, 2025, will be performed in San Antonio, Texas. The award carries no small business set-aside designation, reflecting Werfen USA LLC's status as a full-sized contractor competing across federal procurement opportunities. Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency to Werfen USA LLC, a for-profit limited liability company based in Bedford, Massachusetts. The contract is for the delivery of medical consumables, with a ceiling value of $5,566.70 and a completion date of July 1, 2025. Werfen USA LLC is a manufacturer of in vitro diagnostic (IVD) equipment, reagents, and services for clinical laboratories and point-of-care medical settings. The company has...
- This federal contract award is for the delivery of medical consumables to the Defense Health Agency (DHA), a defense agency within the U.S. Department of Defense. The contract was awarded to Werfen USA LLC, a manufacturer of in vitro diagnostic equipment, reagents, and services for clinical laboratories and point-of-care medical settings. The contract is a Blanket Purchase Agreement (BPA) call with a ceiling value of $16,877.10 and a firm fixed price pricing type. The contract has an ultimate...
- This federal contract award is for the procurement of research supplies and miscellaneous laboratory consumables from Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic (IVD) equipment and reagents. The contract, valued at $18,541.00, is a Blanket Purchase Agreement (BPA) call with a firm fixed price. The funding agency is the Defense Health Agency, a defense agency. The contract does not have a small business set-aside designation, indicating Werfen USA LLC...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded to Werfen USA LLC, a manufacturer of in vitro diagnostic equipment, reagents, and services. The $4,699.10 contract was issued by the Defense Health Agency (DHA) for the provision of research supplies and consumables. The award does not have a set-aside designation, indicating Werfen USA LLC competed as a full-sized contractor. The contract has an ultimate completion date of April 21, 2025. Werfen USA LLC is a...
- The Defense Health Agency awarded a $19,174.64 firm fixed-price Blanket Purchase Agreement (BPA) call to Werfen USA LLC for laboratory reagents, with an ultimate completion date of September 30, 2025. This contract, awarded on July 1, 2025, represents a delivery order against an existing BPA vehicle and does not include a small business set-aside designation. Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and reagents, will perform the work at its...
- The U.S. Defense Health Agency awarded a $16,431.30 Firm Fixed Price BPA Call contract to Werfen USA LLC, a manufacturer and supplier of in vitro diagnostic equipment, reagents, and services for clinical laboratories and point-of-care settings. The contract is for the delivery of multiple medical supplies and ELISA test kits, with a period of performance through September 30, 2024. Werfen USA LLC is a prime contractor that holds Indefinite Delivery/Indefinite Quantity and Blanket Purchase...
- The U.S. Defense Health Agency awarded a firm fixed-price Blanket Purchase Agreement (BPA) call contract to Werfen USA LLC, a manufacturer of in vitro diagnostic equipment, reagents, and services. The contract, valued at $19,732.50, is to provide reagents and consumables for autoimmune assays. This BPA contract, which has no set-aside designation, enables the agency to efficiently obtain specialized diagnostic products and services from an established vendor to support healthcare services for...
- FA239625AB007Blanket Purchase Agreement
- FA239625AB007-FA239625FB247BPA Call
The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call to Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and laboratory testing supplies, on September 15, 2025. This firm fixed-price BPA call carries a ceiling value of $41,454.06 and is scheduled for completion by September 18, 2025. The award supports the automated autoimmune testing capabilities provided by Werfen USA, leveraging the company's expertise in supplying advanced diagnostic technologies to federal healthcare systems. This contract was not designated as a set-aside and represents a direct award to the full-sized contractor through an existing BPA vehicle. Werfen USA LLC brings substantial experience in federal healthcare procurement, having established multiple IDIQ and BPA contract vehicles across agencies including the Department of Veterans Affairs and the Defense Health Agency. The company specializes in providing sophisticated laboratory instrumentation, reagents, and consumables that support clinical diagnostic operations across federal medical facilities. This particular call order contributes to the Defense Health Agency's mission of providing healthcare services to the military health system, enabling access to specialized autoimmune testing capabilities necessary for comprehensive patient diagnostics and treatment planning.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.5k | 9/15/25 |